Large-scale testing (Phase 3)Study completedNCT02675790
What this trial is testing
Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaStroke
Vanderbilt University Medical Center 120